| Literature DB >> 33918616 |
Sung-Woo Kim1, Won-Sang Jung1, Jeong-Weon Kim2, Sang-Seok Nam3, Hun-Young Park1,4.
Abstract
Hypoxic training is often performed by competitive swimmers to enhance their performance in normoxia. However, the beneficial effects of aerobic continuous and interval training under hypoxia on hemodynamic function, autonomic nervous system (ANS) function, and endurance exercise performance remain controversial. Here we investigated whether six weeks of aerobic continuous and interval training under hypoxia can improve hematological parameters, hemodynamic function, ANS function, and endurance exercise performance versus normoxia in amateur male swimmers. Twenty amateur male swimmers were equally assigned to the hypoxic training group or normoxic training group and evaluated before and after six weeks of training. Aerobic continuous and interval training in the hypoxia showed a more significantly improved hemodynamic function (heart rate, -653.4 vs. -353.7 beats/30 min; oxygen uptake, -62.45 vs. -16.22 mL/kg/30 min; stroke volume index, 197.66 vs. 52.32 mL/30 min) during submaximal exercise, ANS function (root mean square of successive differences, 10.15 vs. 3.32 ms; total power, 0.72 vs. 0.20 ms2; low-frequency/high-frequency ratio, -0.173 vs. 0.054), and endurance exercise performance (maximal oxygen uptake, 5.57 vs. 2.26 mL/kg/min; 400-m time trial record, -20.41 vs. -7.91 s) than in the normoxia. These indicate that hypoxic training composed of aerobic continuous and interval exercise improves the endurance exercise performance of amateur male swimmers with better hemodynamic function and ANS function.Entities:
Keywords: aerobic continuous and interval training; amateur male swimmers; autonomic nervous system function; endurance exercise performance; hemodynamic function; hypoxia
Year: 2021 PMID: 33918616 PMCID: PMC8068973 DOI: 10.3390/ijerph18083944
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Subjects’ characteristics.
| Variable | NTG ( | HTG ( | |
|---|---|---|---|
| Environmental condition (mmHg) | Normoxia (760 mmHg) | Hypoxia (526 mmHg) | - |
| Age (years) | 23.90 ± 3.07 | 24.00 ± 3.06 | 0.943 |
| Height (cm) | 176.3 ± 5.69 | 176.36 ± 6.04 | 0.988 |
| Weight (kg) | 69.89 ± 13.40 | 70.18 ± 10.94 | 0.958 |
| BMI (kg/m2) | 23.04 ± 2.88 | 23.05 ± 1.60 | 0.992 |
| Percent body fat (%) | 23.24 ± 3.88 | 23.28 ± 3.91 | 0.982 |
Values are expressed as the mean ± standard deviation. BMI, body mass index; HTG, hypoxic training group; NTG, normoxic training group.
Figure 1Study design. HRmax, maximal heart rate; VO2max, maximal oxygen uptake.
Changes in body composition before and after training by group.
| Measures | NTG ( | HTG ( | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Before | After | Mean Change | Before | After | Mean Change | Time | Group | Interaction | |
| Weight (kg) | 69.89 ± 13.40 | 69.30 ± 13.24 | −0.60 | 70.18 ± 10.94 | 70.01 ± 11.34 | −0.17 | 0.098 (0.179) | 0.000 | 0.032 |
| BMI (kg/m2) | 23.04 ± 2.88 | 22.58 ± 2.33 | −0.46 | 23.05 ± 1.60 | 22.44 ± 1.58 | −0.61 | 0.205 | 0.000 | 0.005 |
| Percent body fat (%) | 23.24 ± 3.88 | 23.18 ± 3.65 | −0.06 | 23.18 ± 3.65 | 22.57 ± 3.90 | −0.71 | 0.062 | 0.002 | 0.045 |
Values are expressed as mean ± standard deviation. BMI, body mass index; CI, confidence interval; HTG, hypoxic training group; NTG, normoxic training group. Significant interaction or main effect: † p < 0.05.
Changes in hematological parameters before versus after training by group.
| Measures | NTG ( | HTG ( | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Before | After | Mean Change | Before | After | Mean Change | Time | Group | Interaction | |
| RBC (×106/µL) | 4.70 ± 0.49 | 4.57 ± 0.50 | −0.14 * | 5.16 ± 0.44 | 4.84 ± 0.43 | −0.32 * | 0.820 | 0.144 | 0.417 |
| Hb (g/dL) | 14.79 ± 1.43 | 14.41 ± 1.46 | −0.38 * | 15.51 ± 1.21 | 14.64 ± 1.31 | −0.87 * | 0.806 | 0.033 | 0.397 |
| Hct (%) | 44.35 ± 3.41 | 43.95 ± 3.73 | −0.40 | 46.40 ± 3.19 | 43.99 ± 3.46 | −2.41 * | 0.642 | 0.025 | 0.479 |
| EPO (mU/mL) | 9.11 ± 2.22 | 10.16 ± 3.47 | 2.30 | 10.16 ± 3.47 | 15.25 ± 2.00 | 5.09 | 0.593 | 0.271 | 0.173 |
| MCV (μm2) | 94.58 ± 3.52 | 96.54 ± 3.40 | 1.95 | 90.15 ± 2.90 | 91.03 ± 2.16 | 0.88 | 0.456 | 0.444 | 0.107 |
| MCH (μg) | 31.49 ± 1.17 | 31.61 ± 1.04 | 0.12 | 30.14 ± 1.32 | 30.29 ± 1.30 | 0.16 | 0.135 | 0.258 | 0.003 |
| MCHC (g/dL) | 33.30 ± 0.84 | 32.75 ± 0.63 | −0.55 | 33.42 ± 0.91 | 33.27 ± 0.96 | −0.15 | 0.310 | 0.042 | 0.128 |
Values are expressed as means ± standard deviations. CI, confidence interval; EPO, erythropoietin; Hb, hemoglobin; Hct, hematocrit; HTG, hypoxic training group; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; NTG, normoxic training group; RBC, red blood cells. Significant interaction or main effect: † p < 0.05; Significant difference before and after training: * p < 0.05.
Changes in hemodynamic function during submaximal exercise for 30 min before and after training by group.
| Measure | NTG ( | HTG ( | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Before | After | Mean Change | Before | After | Mean Change | Time | Group | Interaction | |
| HR | 4980.3 | 4626.6 | −353.7 | 4911.3 | 4257.9 | −653.4 | 0.795 | 0.193 | 0.256 |
| VO2 | 1130.4 | 1114.2 | −16.22 | 1115.8 | 1053.3 | −62.45 | 0.473 | 0.014 | 0.237 |
| SVi | 1497.8 | 1550.1 | 52.32 | 1514.3 | 1712.0 | 197.66 | 0.568 | 0.135 | 0.308 |
| COi | 240.9 | 224.9 | −15.95 | 251.8 | 227.6 | −24.25 | 0.204 | 0.043 | 0.011 |
Values are expressed as means ± standard deviations. CI, confidence interval; COi, cardiac output index; HTG, hypoxic training group; HR, heart rate; NTG, normoxic training group; SVi, stroke volume index; VO2, oxygen uptake. Significant interaction or main effect: † p < 0.05; Significant difference before versus after training: * p < 0.05.
Changes in autonomic nervous system function before versus after training by group.
| Measures | NTG ( | HTG ( | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Before | After | Mean Change | Before | After | Mean Change | Time | Group | Interaction | |
| SDNN (ms) | 54.06 ± 6.06 | 55.11 ± 6.60 | 1.04 | 52.91 ± 11.54 | 59.16 ± 9.83 | 6.25 | 0.200 | 0.009 | 0.113 |
| RMSSD (ms) | 32.18 ± 7.91 | 35.50 ± 8.81 | 3.32 | 31.18 ± 8.31 | 41.33 ± 9.60 | 10.15 | 0.533 | 0.025 | 0.227 |
| TP (ms2) | 8.04 ± 0.22 | 8.24 ± 0.26 | 0.20 | 7.75 ± 0.47 | 8.47 ± 0.40 | 0.72 | 0.685 | 0.002 | 0.405 |
| LF (ms2) | 6.64 ± 0.48 | 6.46 ± 0.36 | −0.18 | 6.62 ± 0.49 | 6.30 ± 0.59 | −0.32 | 0.463 | 0.011 | 0.062 |
| HF (ms2) | 6.40 ± 0.38 | 6.56 ± 0.49 | 0.17 | 6.01 ± 0.89 | 6.69 ± 0.65 | 0.69 | 0.392 | 0.015 | 0.192 |
| LF/HF ratio | 1.04 ± 0.071 | 0.986 ± 0.048 | 0.054 | 1.12 ± 0.178 | 0.948 ± 0.127 | −0.173 | 0.516 | 0.012 | 0.226 |
| Serum cortisol (μg/dL) | 14.41 ± 5.23 | 12.97 ± 3.75 | −1.44 | 14.29 ± 1.63 | 10.93 ± 2.37 | −3.36 | 0.320 | 0.035 | 0.070 |
Values are expressed as mean ± standard deviation. CI, confidence interval; HF, high-frequency; HTG, hypoxic training group; LF, low-frequency; NTG, normoxic training group; RMSSD, root mean square of successive differences; SDNN, standard deviation of NN intervals; TP, total power. Significant interaction or main effect: † p < 0.05; Significant difference before versus after training: * p < 0.05.
Figure 2Changes in endurance exercise performance parameters before versus after training by group. (A) Change in VO2max before versus after exercise training in each environmental condition. (B) Change in the 400-m time trial records before versus after exercise training in each environmental condition. HTG, hypoxic training group; NTG, normoxic training group; VO2max, maximum oxygen uptake. Significant interaction or main effect: † p < 0.05; Significant difference before versus after training: * p < 0.05.